Source-grounded facts extracted from EXPONENT INC's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
EXPONENT INC shareholders approved Advisory Vote on Executive Compensation for Fiscal 2025 at the 2026-06-04 meeting.
“Our stockholders approved, on an advisory basis, the fiscal 2025 compensation of our named executive officers in accordance with SEC rules.”
EXPONENT INC shareholders approved Ratification of KPMG as our Independent Registered Public Accountants for Fiscal 2026 at the 2026-06-04 meeting.
“Our stockholders ratified our selection of KPMG LLP as our independent registered public accounting firm to audit our financial statements for the fiscal year ending January 1, 2027.”
EXPONENT INC shareholders approved Election of Directors at the 2026-06-04 meeting.
“Our stockholders elected George H. Brown, Catherine Ford Corrigan, Ph.D., Carol Lindstrom, Karen A. Richardson, Richard L. Schlenker Jr. and Debra L. Zumwalt.”
EXPONENT INC reported first quarter of fiscal year 2026 ended April 3, 2026 results: revenue $166.3 million, net income $29.6 million, EPS $0.59 per diluted share. Guidance reaffirmed.
“Total revenues and revenues before reimbursements for the first quarter of 2026 increased 14% to $166.3 million and 10% to $151.8 million, respectively, as compared to $145.5 million and $137.4 million in the first quarter of 2025. Net income increased to $29.6 million, or $0.59 per diluted share, in the first quarter of 2026, as compared to $26.7 million, or $0.52 per diluted share, in the same period of 2025.”
Eric Guyer resigned as Group Vice President at EXPONENT INC.
“On October 28, 2024, Eric Guyer, Ph.D. tendered his resignation, effective November 8, 2024, from his role as Group Vice President of Exponent, Inc.”
EXPONENT INC reported first quarter of fiscal year 2024 ended March 29, 2024 results: revenue $144.9 million, net income $30.1 million, EPS $0.59 per diluted share. Guidance raised.
“Total revenues and revenues before reimbursements for the first quarter of 2024 increased 3.3% to $144.9 million and 6.6% to $137.2 million, respectively, as compared to $140.3 million and $128.7 million in the first quarter of 2023, respectively. Net income increased to $30.1 million, or $0.59 per diluted share, in the first quarter of 2024, as compared to $29.1 million, or $0.56 per diluted share, in the same period of 2023.”
Brian Kundert was appointed as Chief Human Resources Officer at EXPONENT INC.
“On February 26, 2024, Exponent, Inc. (the “Company”) appointed Brian Kundert as Chief Human Resources Officer, effective March 16, 2024.”
Sally Shepard departed as Chief Human Resources Officer at EXPONENT INC.
“On February 2, 2024, Exponent, Inc. announced that Sally Shepard will be retiring from her role as its Chief Human Resources Officer, effective March 15, 2024.”
EXPONENT INC updated its fiscal year 2024 guidance (lowered).
“For fiscal year 2024 as compared to fiscal year 2023, Exponent anticipates: Revenues before reimbursements to be flat to down in the low-single digits; and, EBITDA 1 to be 25.75% to 26.5% of revenues before reimbursements.”
EXPONENT INC reported fiscal year 2023 ended December 29, 2023 results: revenue $536.8 million, net income $100.3 million, EPS $1.94 per diluted share.
“Total revenues increased 4.6% to $536.8 million for fiscal year 2023, as compared to $513.3 million in fiscal year 2022. Revenues before reimbursements increased 7.2% to $497.2 million, as compared to $463.8 million in fiscal year 2022. Net income was $100.3 million, or $1.94 per diluted share, during fiscal year 2023, as compared to $102.3 million, or $1.96 per diluted share, in fiscal year 2022.”
EXPONENT INC reported fourth quarter ended December 29, 2023 results: revenue $122.9 million, net income $20.9 million, EPS $0.41 per diluted share.
“Total revenues decreased 3.5% to $122.9 million in the fourth quarter of 2023, as compared to $127.4 million in the fourth quarter of 2022. Revenues before reimbursements increased 1.1% to $113.9 million, as compared to $112.6 million in the fourth quarter of 2022. Net income decreased to $20.9 million, or $0.41 per diluted share, in the fourth quarter of 2023, as compared to $22.5 million, or $0.44 per diluted share, in the same period of 2022.”
EXPONENT INC reported the third quarter ended September 29, 2023 results: revenue Total revenues and revenues before reimbursements for the third quarter of 2023 increased 5% to $133.3 million and 9% to, net income Net income increased to $24.5 million, EPS $0.48 per diluted share. Guidance reaffirmed.
“Exponent, Inc. issued a press release announcing its financial results for the third quarter ended September 29, 2023.”
Steven J. Murray resigned as Group Vice President at EXPONENT INC.
“On October 2, 2023, Steven J. Murray, Ph.D. tendered his resignation, effective October 13, 2023, from his role as Group Vice President of Exponent, Inc.”
EXPONENT INC shareholders approved non-binding recommendation to hold future Say-on-Pay advisory votes every one year.
“Based on the results of the stockholder vote at the Annual Meeting, including the stockholders’ non-binding recommendation to hold future Say-on-Pay advisory votes every one year, the board of directors of the Company has determined that Say-on-Pay advisory votes will be conducted annually.”
EXPONENT INC reported first half of 2023 results: revenue $280.5 million, net income $54.9 million, EPS $1.06 per diluted share. Guidance reaffirmed.
“Total revenues and revenues before reimbursements for the first half of 2023 increased 8.4% to $280.5 million and 9.4% to $258.4 million, respectively, as compared to $258.8 million and $236.1 million in the same period one year ago. Net income was $54.9 million, or $1.06 per diluted share, in the first half of 2023, as compared to $55.4 million, or $1.05 per diluted share, in the same period of 2022.”
EXPONENT INC reported second quarter ended June 30, 2023 results: revenue $140.2 million, net income $25.7 million, EPS $0.50 per diluted share. Guidance reaffirmed.
“Total revenues and revenues before reimbursements for the second quarter of 2023 increased 7.6% to $140.2 million and 9.7% to $129.7 million as compared to $130.3 million and $118.2 million in the second quarter of 2022, respectively. Net income was $25.7 million, or $0.50 per diluted share, in the second quarter of 2023, as compared to $25.8 million, or $0.49 per diluted share, in the same period of 2022.”
EXPONENT INC shareholders approved Advisory Vote on Frequency of Stockholder Votes to Approve Executive Compensation at the 2023-06-08 meeting.
“Proposal Four: Advisory Vote on Frequency of Stockholder Votes to Approve Executive Compensation Our stockholders approved, on an advisory basis, that an advisory vote on the compensation of our named executive officers be held every year.”
EXPONENT INC shareholders approved Advisory Vote on Executive Compensation for Fiscal 2022 at the 2023-06-08 meeting.
“Proposal Three: Advisory Vote on Executive Compensation for Fiscal 2022 Our stockholders approved, on an advisory basis, the fiscal 2022 compensation of our named executive officers in accordance with SEC rules.”
EXPONENT INC shareholders approved Ratification of KPMG as our Independent Registered Public Accountants for Fiscal 2023 at the 2023-06-08 meeting.
“Proposal Two: Ratification of KPMG as our Independent Registered Public Accountants for Fiscal 2023 Our stockholders ratified our selection of KPMG LLP as our independent registered public accounting firm to audit our financial statements for the year ending December 29, 2023.”
EXPONENT INC shareholders approved Election of Directors at the 2023-06-08 meeting.
“Proposal One: Election of Directors Our stockholders elected George H. Brown, Catherine Ford Corrigan, Ph.D., Paul R. Johnson, Ph.D., Carol Lindstrom, Karen A. Richardson, and Debra L. Zumwalt.”
EXPONENT INC reported first quarter ended March 31, 2023 results: revenue $140.3 million, net income $29.1 million, EPS $0.56 per diluted share. Guidance reaffirmed.
“Total revenues and revenues before reimbursements for the first quarter of 2023 increased 9.2% to $140.3 million and $128.7 million, respectively, as compared to $128.5 million and $117.9 million in the first quarter of 2022, respectively. Net income was $29.1 million, or $0.56 per diluted share, in the first quarter of 2023, as compared to $29.6 million, or $0.56 per diluted share, in the same period of 2022.”
Karen Richardson was appointed as director at EXPONENT INC.
“On February 15, 2023, Exponent, Inc.’s (the “Company”) Board of Directors (the “Board”) increased its size from six to seven members and appointed Karen Richardson to the Board.”
EXPONENT INC reported fiscal year 2022 ended December 30, 2022 results: revenue $513.3 million, net income $102.3 million, EPS $1.96 per diluted share.
“before reimbursements in the fourth quarter of 2021. Fiscal Year 2022 Financial Results Total revenues and revenues before reimbursements for fiscal year 2022 increased 10.1% to $513.3 million and 6.7% to $463.8 million, respectively, as compared to $466.3 million and $434.9 million in fiscal year 2021. Excluding the impact of foreign exchange, revenues before”
EXPONENT INC reported the fourth quarter ended December 30, 2022 results: revenue $127.4 million, net income $22.5 million, EPS $0.44 per diluted share.
“for tomorrow,” continued Dr. Corrigan. Fourth Quarter Financial Results Total revenues and revenues before reimbursements for the fourth quarter of 2022 increased 12.2% to $127.4 million and 7.9% to $112.6 million as compared to $113.5 million and $104.3 million in the fourth quarter of 2021, respectively. Excluding the impact of foreign exchange, revenues before”
EXPONENT INC: Adopted amended and restated bylaws updating advance notice requirements for stockholder proposals and nominations, clarifying special meeting requests, universal proxy rules compliance, and aligning with Delaware law changes (effective 2022-12-15).
“On December 15, 2022, the board of directors (the “Board”) of Exponent, Inc. (the “Company”) adopted amended and restated bylaws of the Company (the “Amended and Restated Bylaws”), with immediate effect.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.